Valirx Share Discussion Threads

[412069] 06/6/2023 14:29

Getting desperate now I see Porky, you’ve been rumbled over on lse so trying it on with the few posters we have on here.

[porky9] 06/6/2023 14:11

@Siliconmark
Based on a rough calculation, to have any chance of getting lab revenues to ultimately provide a stable level of income, they need at least £2.5m Raise and extend the working capital runway to 18mths from H2

AND that is ONLY if they hit the ground running and drive new lab business hard, Jury out on that one as they have NEVER so much as invoiced a penny in the past, yet now expected to get towards £2.5m revenue to break even in record time.

Headway of 50m is ideally what they need, if they go for 30m and raise £1.5m now they will be back to the table for raise number 7 within short time. My view is get the placing done for what you need to be clear for 18mths rather than wasting time on multiple further small raises.

oh and @wulber THX getting funded is dead. @Jason, yes pumping crew have this fantastic story about a Delaware business creating an off shore company which will fun THX - honestly its utter utter boll@x but some (namely the ramping crew) are buying into this BS.

Somebody from a previous placing IMO needs to drop a load of stock here BUT for volume CENKOS will currently only give you 7.5p hence they need a spike ideally to get out - going to get interesting

Suzy's presentation will set the scene.

[jasonpugh] 06/6/2023 09:02

Whats all this talk on lse about delaware and usa listing ? Bit of columbo work being done on lse i see. Porks you get individual likes on your comments. Are you training a new apprentice for early morning posts? 🫣

[siliconmark] 06/6/2023 08:29

This is funny, Porky.
You stated categorically that it would be 40-50m and that SH had no place dictating any differently and no influence.

Now SH have got buy and build shelved, and you’ve reduced your estimate to 30m due to SH reactions.

Is it only you who can’t see it? :)

[412069] 06/6/2023 08:24

Give it up Porky you are making yourself look desperate now pal.

[wulber] 06/6/2023 07:47

Porky, please stop!Can you not see your two pints of contention have now gone.1. THX and 201 deal still on2. No placing

[porky9] 06/6/2023 06:46

Interesting, I noted a number of new posters joining on LSE to start a Pump and dump yesterday, spinning some story about a company being formed offshore, never read so much tripe in all my days.

I have seen this activity before normally before a placing. It would not surprise me if the brokers have already put out call to see if there is further placement support and at what level. This could be why no posts by Adam or nick all of a sudden.

It’s a rinse repeat process we have seen so many times, only issue now is practically everyone is catching on to the game.

At the end of the day you can only get a placing away at a level the market will support at. IMO what Suzy needs is headroom of 50m shares. She will likely ask for less due to SH reactions, suspect 30m - once they have the headroom they can issue at any SO level they see fit that they can get support at.

I still stand by 5p top side. If that were the case and they only secure 30m headroom it caps any raise at £1.5m before costs IMO unless the ramping club can pump the share price up to try and get it away at a higher price, frankly I just don’t see it in the current climate, also shareholders are done with Jam now, they are not that stupid.

Will get interesting for sure. Possibility she will offer Adam an NED post to save the boards asses and give him a big share option to cover dilution in support - that’s what I would do in this position. Time will tell.

[porky9] 06/6/2023 06:17

@Jay4u
The RNS service is not a PR service. They can only release news to you IF there is news to report that would possibly affect the share price.The statement yesterday was the most Up to date position.

There was an acknowledgement that they will build the business further before they buy an asset the comment regarding the switch from “buy and build” to “build and buy” however there is no detail on that until the presentation in a week or so time.

I keep saying this but the cash runway is 7 months from H2, the results statement shows the massive increase in cash burn. Watch this space, they will ask for headroom shares shortly, it’s commercially the right thing to do and will be a resolution for the AGM end of the month to pass that and re-elect the board.

They would be foolish not to shore up the rest of the capital, as such I envisage the placement will likely land after the AGM possibly 3rd July and certainly in H2.

Good luck

[jayj4u] 05/6/2023 21:50

We will get more RNS before the zoom call next week. Todays RNS didn't give any information on our drugs. All it said was no more placing I.e no more buy and build. We needed this or no one would buy and hold. They seem to have enough cash to get us close to a deal. At least there will be no placing this year!

[sooty snipes] 05/6/2023 17:03

412069..............I hope so. Otherwise she wants voting off. If Adam was willing to take on the role we would see a bit of action.

[412069] 05/6/2023 14:56

Watch this space Sooty between now and the AGM news will come it has to.

[wulber] 05/6/2023 14:47

At least 201 and THX is still on which is good news, albeit slow as the RNS said - l guess the rest will follow so actually feel quite upbeat for 2023!

[sooty snipes] 05/6/2023 12:32

Dilly has a lot to answer for. She's stealing a living from shareholders. Her handling of 201 is an absolute disgrace. She suckered a lot of shareholders to buying more shares with her "Full of confidence and unconcerned" Tweet on Twitter. How she has still got the job of CEO beggars belief. Add to that Japan and Barcelona. Nothing. She's incapable of closing a deal. ValiRx? great lifestyle business but please don't mention to her about buying shares because she'll rear up and chastise you for daring to question her personal finances.

[412069] 05/6/2023 09:38

Still not 4p Franco and more likely to end today above or around 10p with more news to come pre agm.

[francoismyname] 05/6/2023 09:10

Placing incoming.

Jam tomorrow needs funding.

Look and learn

[siliconmark] 05/6/2023 08:27

Sorry it didn’t work out for you Ben. You sound a bit stressed, hope your next play is good for you. Take care now.

[siliconmark] 05/6/2023 08:11

Well it’s certainly started off better than yours.

[ben gibbons] 05/6/2023 07:55

Just pointed out facts Mark. Nothing more than that.Have yourself a grand day :-)

[siliconmark] 05/6/2023 07:44

Darkhero, it must have been difficult to type that knelt down in front of Porky.
Accept the fact it wasn’t the RNS you expected or wanted.

[ben gibbons] 05/6/2023 07:35

The rampy squad will undoubtedly get my post removed from LSE as it does not fit their pro echo chamber bb so i will post it here also.The Directors are continuing to explore sources of finance available to the Group and based upon initial discussions with a number of existing and potential investors they have a reasonable expectation that they will be able to secure sufficient cash inflows for the Group to continue its activities beyond the 12 months from the date of approval of these financial statements. The Company carries out regular fund-raising exercises in order that it can provide the necessary working capital for the Group. Further funds may be required to finance the Group's work programme. The Board expects to continue to raise additional funding as and when required to cover the Group's development, primarily from the issue of further shares. In January 2023, the Company raised approximately £1.3m, before expenses, through the issue of new ordinary shares. In the event that additional financing is not secured when it is required, the Group would need to consider: · reducing and/or deferring discretionary spending on one or more research and development programmes; and/or · restructuring operations to change its overhead structure. Only have enough cash for 12 months, shareholders would need to allow headroom, if not it could hit the fan.

[porky9] 03/6/2023 11:51

@Ben Gibbons
It’s certainly an interesting view point that’s for sure.

Despite my often critical analysis of some of the BOD decisions, I kind of always kept an optimistic view, the glass half full kind of thing that 201 “Could” work and at the very least should be on a decent set up phase 2 trial to prove it either way but getting someone to pay us an upfront and invest circa £12m minimum to set the trial up was the challenge and more so in this biotech funding drought.

The more it drags on the more you do wonder. I always wondered why in addition to Stella and the BOD refusing to buy why this Ken fella at THX was also not taking a declared position here? After all if he was so confident of funding, he would know VAL share price would reflect that positively and it would be a no brainier but even he has kept his hands in his pocket, won’t even pay us lab fees.

I guess another factor is there are so many biotech mouths to feed in this funding drought, some brilliant innovations coming though and with 201 being what? 10 yrs old now? The big boys are chancing phase trial cash on other drugs. Be interesting to see how this plays out.

First hurdle will be Mondays results statement, if they have over spent against forecast the share price will tank and Nick and Adam will need to Chuck more cash at this to try and prop the share price up at this false level. If it’s in line then it might hold. Then a week later in comes the share headroom request.

Talking to a few contacts, I actually asked if placement shares were offered tomorrow at 5p would you buy. The resounding reply was no, not with this BOD, they think the BOD have created a lifestyle business, it’s all about the management and nobody is confident. they are not convinced on the pre clinical like Barcelona either, if it was good to go, they think we would already know and not extended. Based on form, they think extending these drugs is a way to avoid confirming they don’t work and damaging the mcap. CLX had the best feed back and hope it gets a chance at finding a backer for phase trials. Likely no money upfront but maybe a milestone payment further down the line on results if they can get it backed. You never know, you only need one good one to work but I think that will be a few years off yet but it needs good handling.

Personally, I think it’s all about a start up labs business now, with CLX as an outside runner. The legacy range that old now, with more advanced options now available they are unlikely to get backers for phase trials. Trials being so bloody expensive really doesn’t help either.

Anyhow, only a week odd to go now to hear from the horses mouth and the forward plans will be put before us. Good luck

[ben gibbons] 02/6/2023 15:19

WooooowWhat a very astute comment.I said a while back if 201 was that good then big pharma would be over it like a cheap suit.Very telling and this comment hits the nail on the head.Being strung along because 201 is a blank.Borsaci06Posts: 997Price: 9.25No OpinionCommercial ?Today 14:06Imho Except Delaware company No interest from established pharma indicates VAL series peptide have no commercial value in their eyes. Ceo/Bod know this and hanging on to TheoremRx as last chance for VAL series. If Valirx peptide/repurposed compound classed as oil/ gas show in exploration company, it would have been declared as non-commercial by now. Those willing to ditch TheoremRx & replace Ceo / Bod have not come up with better proposal, deal ...... for Val201. New additions to pipeline & lab will determine the faith of this company, rest is history. Spin in a spin for last 17 years got company almost nowhere, but speculating/manipulating/pumping/dumping investors got good return for their investment. More hopium will be the end result of changing Ceo/Bod. Put your better proposal, offer ...... for Val201 to Ceo/Bod and rest of the investors here. Did you arrange/find buyer for Val201 or will you, if changes happened at company? Show us the money

[porky9] 02/6/2023 14:51

@JasonPugh
Makes FA difference, only:-

1. What they actually deliver (Jam tomorrow dead)
2. How many headway shares they need ready to issue
3. If still pushing on with acquisition before 30/6 and is Buy and Build still on

Are they going to give Adam a NED position to save own asses and give him a massive share option to cover dilution at placing OR are they going to press on without him, do the placing and Adam then go hostile later to get elected to sort the BOD out.

I’m 50/50 preservation first, the bod won’t want to rock the boat pre re-election but equally they need headway shares....... will be interesting

[jasonpugh] 02/6/2023 14:33

@porky. You need to read the full government response. I only quoted a very small section. Not only speed of trials…much much more. Please read. 🫣